Results 71 to 80 of about 40,571 (305)

High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections

Discoveries, 2021
Severe COVID-19 disease is associated with an increase in pro-inflammatory markers, such as IL-1, IL-6, and tumor necrosis alpha, less CD4 interferon-gamma expression, and fewer CD4 and CD8 cells, which increase the susceptibility to bacterial and fungal
K. Bhatt, Arjola Agolli, M. Patel, Radhika Garimella, M. Devi, Efrain Garcia, H. Amin, Carlos Domingue, Roberto Guerra Del Castillo, M. Sanchez-Gonzalez   +9 more
semanticscholar   +1 more source

Mucormycosis in patients with COVID‐19: A cross‐sectional descriptive multicentre study from Iran

Mycoses (Berlin), 2021
The aim of the study was to report clinical features, contributing factors and outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis (CAM).
F. Pakdel, K. Ahmadikia, M. Salehi, Azin Tabari, Rozita Jafari, Golfam Mehrparvar, Y. Rezaie, Shahin Rajaeih, N. Alijani, A. Barać, A. Abdollahi, S. Khodavaisy   +11 more
semanticscholar   +1 more source

Diagnostic and Treatment Challenges of Emergent COVID-Associated-Mucormycosis: A Case Report and Review of the Literature

Antibiotics, 2022
Mucormycosis is a rare fungal infection, with high mortality, commonly associated with diabetes, malignancies, immunosuppressive therapy, and other immunodeficiency conditions.
Manuela Arbune, Anca-Adriana Arbune, Alexandru Nechifor, Iulia Chiscop, Violeta Sapira   +4 more
doaj   +1 more source

Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19

Indian Journal of Ophthalmology, 2021
course of the disease. However, radiological resolution lags clinical resolution.
S. Honavar
semanticscholar   +1 more source

Associated risk factors for post−COVID−19 mucormycosis at a tertiary care centre: A cross−sectional study

Journal of Acute Disease, 2022
Objective: To explore risk factors of mucormycosis in COVID-19 recovered patients. Methods: A total of 101 patients, who were diagnosed with mucormycosis after recovery from COVID-19 and admitted to the Indira Gandhi Institute of Medical Sciences, Patna,
Praphull Deepankar, Govind Kumar, Jyoti Kr Dinkar, Rishav Mittal   +3 more
doaj   +1 more source

The potential for rapid antigen testing for mucormycosis in the context of COVID-19

Expert Review of Molecular Diagnostics, 2023
Introduction Mucormycosis is a highly aggressive angio-invasive disease of humans caused by Mucorales fungi. Prior to the COVID-19 pandemic, mucormycosis was a rare mycosis typically seen in immunocompromised patients with hematological malignancies or ...
C. Thornton
semanticscholar   +1 more source

Disseminated tuberculosis and gastric mucormycosis coinfection

IDCases, 2019
Tuberculosis and mucormycosis coinfection has rarely been reported in the medical literature. We present a case of gastrointestinal (GI) mucormycosis in a diabetic patient with disseminated tuberculosis.
Alexandre Malek, Alejandro De la Hoz, Roberto Arduino, Gabriel M. Aisenberg   +3 more
doaj   +1 more source

Rhino cerebral mucormycosis: a report of two cases and review of literature. [PDF]

, 2011
Mucormycosis is caused by fungi of the order Mucorales and is one of the fulminant and fatal mycotic infections known to human beings with a high mortality rate.
Ashish, Lanjekar, Deepa, Lanjekar, Rakesh, Nagaraju, Shridevi, Bijjal, Sujatha, Reddy S.   +4 more
core   +1 more source

Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review

Annals medicus
Aim This review aims to summarize the epidemiology, etiology, pathogenesis, clinical manifestations, and current diagnostic and therapeutic approaches for mucormycosis.
Mei Liang, Jian Xu, Yanan Luo, Junyan Qu
semanticscholar   +1 more source

COVID-19 and mucormycosis superinfection: the perfect storm

Infection, 2021
The recent emergence of the Coronavirus Disease (COVID-19) disease had been associated with reports of fungal infections such as aspergillosis and mucormycosis especially among critically ill patients treated with steroids.
J. Al-Tawfiq, S. Alhumaid, A. Alshukairi, M. Temsah, M. Barry, Abbas Al Mutair, A. Rabaan, Awad Al-omari, R. Tirupathi, M. Alqahtani, S. AlBahrani, K. Dhama   +11 more
semanticscholar   +1 more source